RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medica Sur SAB de CV Stock

Medica Sur SAB de CV ROE 2024

Medica Sur SAB de CV ROE

0.31

Ticker

MEDICAB.MX

ISIN

MXP510121215

WKN

A1JHBB

In 2024, Medica Sur SAB de CV's return on equity (ROE) was 0.31, a -17.22% increase from the 0.38 ROE in the previous year.

Medica Sur SAB de CV Aktienanalyse

What does Medica Sur SAB de CV do?

Medica Sur SAB de CV is a leading Mexican healthcare company that was originally founded in 1982. Headquartered in Mexico City, Medica Sur operates hospitals, medical clinics, laboratories, and diagnostic centers throughout the country. The company aims to provide comprehensive and high-quality healthcare and has earned an outstanding reputation through its innovative medical technology and expertise. The core business of Medica Sur includes the operation of seven hospitals and clinical facilities in various parts of the country. These facilities provide medical services in general medicine, internal medicine, neurology, oncology, gynecology, urology, pediatrics, ophthalmology, and clinical psychiatry. The company also operates its own laboratory and diagnostic center, where a wide range of tests are performed, including X-rays and CT scans, blood tests, and biopsy examinations. Medica Sur also has a subsidiary called Hospitales Angeles, which specializes in cosmetic surgery. These facilities offer a wide range of beauty treatments, including liposuction, breast augmentation, facelifts, and Botox injections. Another important business area for Medica Sur is education and research. The company operates a prestigious training program for medical professionals such as nurses, specialists, and general practitioners. Furthermore, Medica Sur is active in medical research and invests in innovative technologies and scientific developments aimed at improving the quality and effectiveness of medical care. One of Medica Sur's biggest innovations is the use of robotics in surgery. The company utilizes robots that can respond to the surgeon's movements, thereby enabling higher precision in performing operations. The use of this technology has contributed to the advancement of surgery and opened up new treatment options for patients. Overall, Medica Sur's business model is designed to provide comprehensive and high-quality healthcare in Mexico tailored to the needs and expectations of patients. The company aims to be a leading healthcare company that utilizes innovative technologies and top-notch expertise to improve people's lives. Medica Sur SAB de CV ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Medica Sur SAB de CV's Return on Equity (ROE)

Medica Sur SAB de CV's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Medica Sur SAB de CV's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Medica Sur SAB de CV's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Medica Sur SAB de CV’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Medica Sur SAB de CV stock

What is the ROE (Return on Equity) of Medica Sur SAB de CV this year?

The ROE of Medica Sur SAB de CV this year is 0.31 undefined.

How has the Return on Equity (ROE) of Medica Sur SAB de CV developed compared to the previous year?

The ROE of Medica Sur SAB de CV has increased by -17.22% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Medica Sur SAB de CV?

A high ROE indicates that Medica Sur SAB de CV generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Medica Sur SAB de CV?

A low ROE can indicate that Medica Sur SAB de CV is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Medica Sur SAB de CV affect the company?

A change in ROE (Return on Equity) of Medica Sur SAB de CV can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Medica Sur SAB de CV?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Medica Sur SAB de CV?

Some factors that can influence Medica Sur SAB de CV's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Medica Sur SAB de CV pay?

Over the past 12 months, Medica Sur SAB de CV paid a dividend of 13.06 MXN . This corresponds to a dividend yield of about 37.65 %. For the coming 12 months, Medica Sur SAB de CV is expected to pay a dividend of 13.06 MXN.

What is the dividend yield of Medica Sur SAB de CV?

The current dividend yield of Medica Sur SAB de CV is 37.65 %.

When does Medica Sur SAB de CV pay dividends?

Medica Sur SAB de CV pays a quarterly dividend. This is distributed in the months of June, October, June, June.

How secure is the dividend of Medica Sur SAB de CV?

Medica Sur SAB de CV paid dividends every year for the past 4 years.

What is the dividend of Medica Sur SAB de CV?

For the upcoming 12 months, dividends amounting to 13.06 MXN are expected. This corresponds to a dividend yield of 37.65 %.

In which sector is Medica Sur SAB de CV located?

Medica Sur SAB de CV is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medica Sur SAB de CV kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medica Sur SAB de CV from 5/16/2024 amounting to 1.5 MXN, you needed to have the stock in your portfolio before the ex-date on 5/14/2024.

When did Medica Sur SAB de CV pay the last dividend?

The last dividend was paid out on 5/16/2024.

What was the dividend of Medica Sur SAB de CV in the year 2023?

In the year 2023, Medica Sur SAB de CV distributed 10.485 MXN as dividends.

In which currency does Medica Sur SAB de CV pay out the dividend?

The dividends of Medica Sur SAB de CV are distributed in MXN.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medica Sur SAB de CV

Our stock analysis for Medica Sur SAB de CV Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medica Sur SAB de CV Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.